ICAR: endoscopic skull‐base surgery
EW Wang, AM Zanation, PA Gardner… - International forum of …, 2019 - Wiley Online Library
Background Endoscopic skull‐base surgery (ESBS) is employed in the management of
diverse skull‐base pathologies. Paralleling the increased utilization of ESBS, the literature in …
diverse skull‐base pathologies. Paralleling the increased utilization of ESBS, the literature in …
International consensus statement on allergy and rhinology: sinonasal tumors
EC Kuan, EW Wang, ND Adappa… - International forum of …, 2024 - Wiley Online Library
Background Sinonasal neoplasms, whether benign and malignant, pose a significant
challenge to clinicians and represent a model area for multidisciplinary collaboration in …
challenge to clinicians and represent a model area for multidisciplinary collaboration in …
Induction chemotherapy response as a guide for treatment optimization in sinonasal undifferentiated carcinoma
M Amit, AS Abdelmeguid, T Watcherporn… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE Multimodal therapy is a well-established approach for the treatment of sinonasal
undifferentiated carcinoma (SNUC); however, the optimal sequence of the various …
undifferentiated carcinoma (SNUC); however, the optimal sequence of the various …
PET/CT imaging in treatment planning and surveillance of sinonasal neoplasms
S Akay, JH Pollard, A Saad Eddin, A Alatoum… - Cancers, 2023 - mdpi.com
Simple Summary Sinonasal cancers are rare types of cancer that are often detected at a late
stage, making them difficult to treat. To monitor these cancers closely, advanced imaging …
stage, making them difficult to treat. To monitor these cancers closely, advanced imaging …
SMARCB1 (INI-1)-deficient sinonasal carcinoma: a systematic review and pooled analysis of treatment outcomes
Simple Summary SMARCB1 (INI-1)-deficient sinonasal carcinoma is a rare but locally
aggressive malignancy which usually presents very late with invasion into the orbits and …
aggressive malignancy which usually presents very late with invasion into the orbits and …
The role of elective neck treatment in the management of sinonasal carcinomas: a systematic review of the literature and a meta-analysis
C Galloni, LG Locatello, C Bruno, A Cannavicci… - Cancers, 2021 - mdpi.com
Simple Summary The impact of elective neck treatment (ENT), whether by irradiation or
dissection, on the prognosis of patients with cN0 sinonasal carcinomas remains an …
dissection, on the prognosis of patients with cN0 sinonasal carcinomas remains an …
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment
F Jakimovska, I Stojkovski, E Kjosevska - Current oncology reports, 2024 - Springer
Abstract Purpose of Review The purpose of this review is to analyze the diagnosis and
treatments of the sinonasal malignant tumors throw systematic reviewed literature. The …
treatments of the sinonasal malignant tumors throw systematic reviewed literature. The …
Definitive-intent (chemo) radiotherapy for sinonasal undifferentiated carcinoma
L Wang, J Wang, T Tang, L Yan… - The British Journal of …, 2023 - academic.oup.com
Objective: The current study aimed to investigate the value of definitive-intent (chemo)
radiotherapy in treating sinonasal undifferentiated carcinoma (SNUC) in a single institution …
radiotherapy in treating sinonasal undifferentiated carcinoma (SNUC) in a single institution …
Elective neck treatment in sinonasal undifferentiated carcinoma: Systematic review and meta‐analysis
Sinonasal undifferentiated carcinomas (SNUCs), being an aggressive malignancy with
dismal survival outcome, have given limited consideration regarding management of …
dismal survival outcome, have given limited consideration regarding management of …
Meta‐analysis of multi‐modality therapies in sinonasal undifferentiated carcinoma—A timely update
ASY See, C Chu, ICZY Lim, BKJ Tan… - Clinical …, 2024 - Wiley Online Library
Objectives Sinonasal undifferentiated carcinoma (SNUC) is a rare but aggressive tumour
with very poor prognosis. There are currently no well‐established clinical trials to guide …
with very poor prognosis. There are currently no well‐established clinical trials to guide …